Oct 3, 2025, 07:59 AM by

Oct 3, 2025, 07:59 AM by

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development.

Oct 3, 2025, 07:59 AM by

- Insilico published a new study unveiling Target Identification Pro (TargetPro), a superior disease-specific model, and TargetBench 1.0, the first standardized benchmarking framework for target discovery. - TargetPro achieved 71.6% retrieval of known clinical targets, a 2–3x improvement over large language models (LLMs) such as GPT-4o, Grok3, DeepSeek-R1, Claude-Opus-4, BioGPT, and public platforms like Open Targets. - TargetPro’s predicted novel targets demonstrated 95.7% structure availability, 86.5% druggability, and 46% repurposing potential, outperforming competing systems on all measures. - TargetBench’s explainable AI models revealed disease-specific feature importance patterns, emphasizing the value of disease-specific target identification models. - New gold standard approaches improve accuracy, reliability, and transparency in AI-driven drug discovery.

Oct 2, 2025, 07:40 AM by

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

Oct 2, 2025, 01:01 AM by User Not Found

Bio-IT World | The Pistoia Alliance has launched a new initiative to advance the safe adoption of agentic AI. The initiative sits under the Alliance’s strategic priority to Harness AI to Expedite R&D and alongside its AI/ML Community of Experts, which is actively seeking further funding to continue supporting responsible AI adoption across the industry.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Quantabio has launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 01:01 AM by User Not Found

Bio-IT World | Bio-IT World is now accepting entries for the 2026 Innovative Practices Awards, a competition designed to recognize the most exciting partnerships and projects pushing the life sciences industry forward. The deadline for entry is March 2, 2026, and the $300 application fee will be waived for entrants who meet the early submission deadline of January 30, 2026.

Sep 30, 2025, 08:47 AM by

Sep 30, 2025, 08:47 AM by

Sep 30, 2025, 08:47 AM by

Pathologists readily embrace the shift to digital workflows.

Sep 30, 2025, 01:00 AM by User Not Found

Bio-IT World | Coming up with a medication that produces weight loss or prevents weight gain without any of the miserable side effects associated with top-selling drugs like Ozempic and Zepbound is the holy grail of every pharma company in the obesity space. About 70% of Americans are now considered overweight or obese, but relatively few of them are currently being treated with the otherwise popular weight-loss medications due in large part to side effects associated with the glucagon-like peptide-1 (GLP-1) pathway they activate in the gut and brain to achieve their effects.

Sep 29, 2025, 08:26 AM by

Sep 26, 2025, 01:01 AM by User Not Found

Bio-IT World | A new classification system for recurrent ovarian cancer was developed by scientists at Lausanne University Hospital and the Ludwig Institute for Cancer Research. The system combines genomic sequencing with immune profiling to stratify patients into four immunologic subgroups, laying the groundwork for personalized therapies that could extend survival.

Sep 25, 2025, 08:55 AM by

PubHive launches Generative AI Usage Dashboard to give life sciences teams visibility, compliance, and cost control for responsible AI adoption.

Sep 25, 2025, 08:55 AM by